Apotex launches generic Emend

Press enter to search
Close search
Open Menu

Apotex launches generic Emend

By Sandra Levy - 09/10/2019
Apotex is offering fosaprepitant dimeglumine for injection.

The product is the generic of Merck's Emend. It is an antiemetic (anti-nausea) used together with other medications to prevent nausea and vomiting that may be caused by surgery or cancer chemotherapy.

Fosaprepitant had a market value of approximately $279 million, according to IQVIA.

Fosaprepitant for injection is distributed as 1 vial per carton.

RELATED TOPICS